Watson Pharmaceuticals: Notice on holding an online briefing on the results for the third quarter of 2024
Watson Pharmaceuticals: Notice on Obtaining a Notice of Approval for Supplemental Application for Pancreatic Rhinitis Capsule Drugs
Watson Pharmaceuticals: Announcement on asset impairment preparations for the first three quarters of 2024
Watson Pharmaceuticals: Announcement on the Appointment of the Company\'s Deputy General Manager
Watson Pharmaceuticals: Announcement on changing the name of the holding subsidiary and completing the registration of commercial and commercial changes
Watson Pharmaceuticals: Notice on receipt of approval letter for drug re-registration
Watson Pharmaceuticals: Notice on receipt of approval letter for drug re-registration
Watson Pharmaceuticals: Announcement on the approval of Liuwei Anshen capsules as the country\'s first grade 2 protected variety of traditional Chinese medicine
Watson Pharmaceuticals: Announcement on changes in the company\'s drug production license
Watson Pharmaceuticals: Notice on receipt of approval letter for drug re-registration
Watson Pharmaceuticals: Announcement on the approval of licorice and plum tablets for registration in Singapore
Chongqing Pharscin Pharmaceutical: Notice of Online Performance Presentation for the First Half of 2024
Chongqing Pharscin Pharmaceutical: Announcement on the Action Plan for Double Improvement of Quality and Profit
Chongqing Pharscin Pharmaceutical: Financial Report for the first half of 2024.
Chongqing Pharscin Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Chongqing Pharscin Pharmaceutical: Announcement regarding the receipt of pharmaceutical re-registration approval notice.
Chongqing Pharscin Pharmaceutical: Announcement Regarding Completing Domestic Production Pharmaceutical Filing for the Product.
Chongqing Pharscin Pharmaceutical: Announcement Regarding Completion of Business Registration Changes.
Chongqing Pharscin Pharmaceutical: Announcement regarding the receipt of approval notice for re-registration of active pharmaceutical ingredient.
Chongqing Pharscin Pharmaceutical: Announcement Regarding Changes to the Company's Pharmaceutical Production License
No Data
No Data